Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Automated breast ultrasound (ABUS) allows for reproducible breast imaging without variation based on which sonographer performs the exam. It also can help centers were they are short on qualified breast sonographers.  Breast ultrasound can help identify cancers, or benign cysts, even in women with very dense breast tissue. At the GE Healthcare booth at RSNA.

Automated ultrasound excels for women with dense breasts

Could automated breast ultrasound replace handheld ultrasound?

Thumbnail

Many U.S. websites do not reflect updated lung cancer screening guidelines

Accurate information relative to personal risk is crucial for improving uptake of low-dose CT (LDCT) lung cancer screening, but new data indicate that many websites' content on the topic is out of date. 

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

How do hormonal contraceptives affect breast density?

How recent developments in hormonal contraceptives affect breast density is an important consideration, as an increase in density category increases cancer risk.

healthcare value value-based care money dollar

Contrast-enhanced mammography for breast cancer staging offers significant cost savings

Prior research has shown that not only is contrast-enhanced spectral mammography comparable to CE-MRI in accuracy of loco-regional staging, but some studies have even found it to perform better.

Thumbnail

Risk model-based lung cancer screening more cost-effective than USPSTF guidelines

Using risk model-based strategies to determine who should undergo low-dose CT lung cancer screening is more cost effective than current U.S. Preventive Services Task Force guidelines.

Thumbnail

Large VA trial could change how patients are screened for liver cancer

Researchers involved in the new study propose that abbreviated MRI protocols could offer more accurate assessments of liver lesions than ultrasound. 

Thumbnail

Age and workload affect reader performance for screening mammograms

Age, specialty training and reading volume give readers an edge over their peers when it comes to screening mammogram interpretations.

Thumbnail

AI tool predicts lung cancer without radiologists or clinical histories

The deep learning model was trained to predict risk of lung cancer in the one to six years following completion of an LDCT scan, and it does not require clinical information relative to risk factors to do so.

Around the web

The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Trimed Popup
Trimed Popup